Pallas Health vs Trimi Health
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Pallas Health
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Visit Pallas Health →
Trimi Health
Best for: knowing which pharmacy fills the vial — it names VialsRx
Visit Trimi Health →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Trimi Health opens cheaper — $99/mo against $199, and Trimi Health finishes ahead, 9.4 to 8.0. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Pallas Health
$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.
$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.
Trimi Health
Billed monthly. Flat price at every dose.
Quarterly plan: billed $435 every 3 months.
Bi-annual plan: billed $720 every 6 months.
Annual plan: billed $1,188 yearly upfront (or BNPL via Affirm/Klarna/Afterpay). This is the advertised headline price.
Billed monthly. Flat price at every dose.
Quarterly plan: billed $597 every 3 months.
6-month plan: billed $1,050 every 6 months.
Annual plan: billed $1,500 yearly upfront (or BNPL). This is the advertised headline price.
What’s included
Pallas Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Trimi Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Pallas Health
8.0/10
Trimi Health
9.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Pallas Health | Trimi Health |
|---|---|---|
| Starting Price | $199/mo | ✓$99/mo |
| Features | ✓8 features | 3 features |
| States Available | ✓51 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | ✓ Yes | — |
| FDA Warnings | None | None |
About Pallas Health
$199 and $299 a month are the averages on the compounded plans, with messaging, check-ins and provider care folded in, no membership charged on the side, and the figure unchanged at every dose. Mounjaro, Zepbound, Ozempic and Wegovy sell under their brand names next to compounded tirzepatide and semaglutide. Brentmoor, Inc. is the operator. Disclosure is unusually thorough here: NPIs you can verify against two named advising physicians, Lion MD as clinical partner, six pharmacy partners named, and all 50 states plus DC covered.
Read our full Pallas Health review →About Trimi Health
Trimi Health is a telehealth seller whose compounded GLP-1 pricing is among the lowest available.
Read our full Trimi Health review →Pros & Cons
Pallas Health
What we like
- Semaglutide at $199 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 6 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Trimi Health
What we like
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- Tirzepatide at $125 a month, 53% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 2 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Trimi Health takes it, 9.4 against 8.0, and it is especially strong on knowing which pharmacy fills the vial — it names VialsRx. Pallas Health is no weak second and may fit you better on knowing which pharmacy fills the vial — it names Belmar Pharmacy.
Choose Pallas Health if…
You want knowing which pharmacy fills the vial — it names Belmar Pharmacy and an opening price near $199 a month.
Choose Trimi Health if…
You want knowing which pharmacy fills the vial — it names VialsRx and an opening price near $99 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
SkinnyRx
Starting below a standard dose, with microdose tiers
From $149.25/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial — it names VialsRx
From $99/mo
Get started →Strut Health
Semaglutide at $99/month, 48% under the register median
From $99/mo
Get started →Pallas Health vs Trimi Health: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Pallas Health and Trimi Health head-to-heads in the same category.
- Pallas Health vs Embody
- Pallas Health vs He & She MD
- Pallas Health vs Lean Meds
- Trimi Health vs NextMeds
- Trimi Health vs bmiMD
- Trimi Health vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.